Insights on Covid‐19 with superimposed pulmonary histoplasmosis: The possible nexus

A novel coronavirus (CoV) known as severe acute respiratory syndrome CoV type 2 is the causative agent for the development of CoV disease 2019 (Covid‐19). Covid‐19 may increase the risk of developing pulmonary histoplasmosis due to immune dysregulation. In addition, Covid‐19 may enhance the propagat...

Descripción completa

Detalles Bibliográficos
Autores principales: Almutawif, Yahya A., Al‐kuraishy, Hayder M., Al‐Gareeb, Ali I., Alexiou, Athanasios, Papadakis, Marios, Eid, Hamza M. A., Saad, Hebatallah M., Batiha, Gaber El‐Saber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540147/
https://www.ncbi.nlm.nih.gov/pubmed/37773721
http://dx.doi.org/10.1002/iid3.989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540147/
https://www.ncbi.nlm.nih.gov/pubmed/37773721
http://dx.doi.org/10.1002/iid3.989

Ejemplares similares